- A Patient of Hepatocellular Carcinoma Performed Hepatectomy after Tumor Downing Sizing with Transcatheter Arterial Chemoembolization
-
Seul Ki Min, Sang Gyune Kim, Young Seok Kim, Sae Whan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim
-
Journal of the Korean Liver Cancer Study Group. 2011;11(1):40-45. Published online February 28, 2011
-
-
-
 Abstract
 PDF
- Hepatocellular carcinoma (HCC) is the third most common cancer in korean population. Surgical management is the mainstay
of HCC. Surgical resection and liver transplantation shows the best outcomes in well-selected patients. But few patients are
possible to benefit from surgical resection or liver transplantation. The majority of cases of HCC are unresectable, but there are
no proven treatment modalities for these cases. In small number of articles showed the favorable result of adjuvant chemotherapy,
and transcatheter arterial chemoembolization (TACE) for unresectable HCCs. But there are some drawbacks, such as small
number of sample size and variablity of study design at each studies. Hereby we report a patients of HCC, who was performed
hepatectomy after tumor down sizing with TACE.
|
E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Follow JLC on Twitter